Home > Healthcare > Medical Devices > Therapeutic Devices > pediatric catheters market
Get a free sample of Pediatric Catheters Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Pediatric Catheters Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The pediatric catheters industry is competitive in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products with improved efficiency and cost-effectiveness is among a key market strategy for catheter manufacturers. Some of the leading industry players including Becton, Dickinson and Company, Boston Scientific Corporation, ICU Medical, Inc., Johnson & Johnson Private Limited, Medline Industries, LP, and Medtronic, Plc among others have a substantial presence in the market.
Some of the eminent market participants operating in the pediatric catheters industry include:
The cardiovascular catheter segment share was valued at over USD 2.8 billion in 2023 and will grow significantly through 2032 owing to the widespread prevalence of heart failure, arrhythmias, and coronary artery diseases.
The global pediatric catheters industry was valued at around USD 6.7 billion in 2023 and is expected to reach around USD 12.6 billion by 2032 attributed to the increasing prevalence of pediatric urological conditions, technological advancements in catheters, and growing demand for minimally invasive surgical procedures.
North America pediatric catheters market accounted for USD 2.2 billion in 2023 and is predicted to witness substantial growth through 2032 due to the increasing number of children with congenital heart defects.
Becton, Dickinson and Company, Boston Scientific Corporation, Coloplast Corp, Cook Medical, Edwards Lifesciences Corporation, Getinge AB, ICU Medical, Inc., Johnson & Johnson Private Limited, Medline Industries, LP, and Medtronic, Plc.